SmallCap
CompaniesMapStatistics

㈜아리바이오

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name㈜아리바이오
Business Reg. No.1078742277
CEO정재준
Address경기도 성남시
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products신약개발, 기능성화장품
EstablishedContact
Phone02-2637-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.110111-*******

Investment Metrics


Market Cap
-
Op. Margin
37.79%
ROE
4.26%
Debt Ratio
103.66%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2011-02-15 ~ 2013-02-14201101002802011-02-15
기술평가보증기업(기금)2013-02-15 ~ 2015-02-14201301016712011-02-15
벤처투자유형2015-02-15 ~ 2017-02-14201503000342011-02-15
벤처투자유형2017-02-15 ~ 2019-02-14201703001252011-02-15
벤처투자유형2019-02-15 ~ 2021-02-14201903001332011-02-15
벤처투자유형2021-02-15 ~ 2023-02-14202103001452011-02-15
벤처투자유형2023-02-15 ~ 2026-02-14202302080100342011-02-15
벤처투자유형2026-02-15 ~ 2029-02-14202602240100262011-02-15

Financial Statements


3-Year Financial Data

Revenue CAGR +204.2%

Item202420232022
Revenue

352B

156B

38B

Operating Profit

133B

-101B

-257B

Net Profit

39B

-246B

-321B

Total Assets

1,850B

1,470B

1,549B

Total Liabilities

942B

716B

606B

Total Equity

908B

754B

943B

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
352B

263.6%

vs. 3-Year Avg.: 97B
Operating Profit
133B

174.4%

vs. 3-Year Avg.: -179B
Op. Margin
37.8%

110.2%

vs. 3-Year Avg.: -369.7%
Debt Ratio
103.7%

30.1%

vs. 3-Year Avg.: 79.7%
ROE
4.3%

112.8%

vs. 3-Year Avg.: -33.3%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
정재준대표이사대표

Employment Status


Regular EmployeesContact
CEO정재준

Patent Status

Updated: 2026-02-25

94 Patents
71 Registered
8 in 3 Years
A61 의학/수의학/위생 (172)
A23 식품/식료품 (36)
A01 농업/임업/축산 (6)
C12 생화학/미생물학 (5)
G01 측정/시험 (4)
Patent TitleApplicantApplication No.Filing DateStatus
포스포디에스테라제 타입 5 저해제를 유효성분으로 포함하는 외상 후 스트레스 장애의 예방 또는 치료용 조성물주식회사 아리바이오10202400104272024-01-23공개
텔로머라제 활성화제와 나노 입자를 포함하는 약물 전달용 조성물 및 이를 포함하는 탈모 예방, 개선 또는 치료용 조성물주식회사 아리바이오|주식회사 바이오켐진10202400087932024-01-19등록
텔로머라제 활성화제와 나노 리포좀 입자를 포함하는 약물 전달용 조성물 및 이를 포함하는 탈모 예방, 개선 또는 치료용 조성물주식회사 아리바이오|주식회사 바이오켐진10202400088442024-01-19등록
텔로머라제 활성화제와 나노 입자를 포함하는 약물 전달용 조성물 및 이를 포함하는 탈모 예방, 개선 또는 치료용 조성물주식회사 아리바이오|주식회사 바이오켐진10202400087532024-01-19등록
텔로머라제 활성화제와 나노 리포좀 입자를 포함하는 약물 전달용 조성물 및 이를 포함하는 탈모 예방, 개선 또는 치료용 조성물주식회사 아리바이오|주식회사 바이오켐진10202400088792024-01-19등록

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "경기도 성남시",
  "ceo_name": "정재준",
  "certificate": [
    {
      "cert_number": "20110100280",
      "changes": "",
      "disclosure_date": "2011-02-15",
      "first_cert_date": "2011-02-15",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2011-02-15 ~ 2013-02-14"
    },
    {
      "cert_number": "20130101671",
      "changes": "",
      "disclosure_date": "2013-03-13",
      "first_cert_date": "2011-02-15",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2013-02-15 ~ 2015-02-14"
    },
    {
      "cert_number": "20150300034",
      "changes": "",
      "disclosure_date": "2015-02-05",
      "first_cert_date": "2011-02-15",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2015-02-15 ~ 2017-02-14"
    },
    {
      "cert_number": "20170300125",
      "changes": "",
      "disclosure_date": "2017-03-16",
      "first_cert_date": "2011-02-15",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2017-02-15 ~ 2019-02-14"
    },
    {
      "cert_number": "20190300133",
      "changes": "",
      "disclosure_date": "2019-02-14",
      "first_cert_date": "2011-02-15",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2019-02-15 ~ 2021-02-14"
    },
    {
      "cert_number": "20210300145",
      "changes": "",
      "disclosure_date": "2021-02-10",
      "first_cert_date": "2011-02-15",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2021-02-15 ~ 2023-02-14"
    },
    {
      "cert_number": "20230208010034",
      "changes": "",
      "disclosure_date": "2023-02-08",
      "first_cert_date": "2011-02-15",
      "no": "7",
      "type": "벤처투자유형",
      "valid_period": "2023-02-15 ~ 2026-02-14"
    },
    {
      "cert_number": "20260224010026",
      "changes": "",
      "disclosure_date": "2026-02-24",
      "first_cert_date": "2011-02-15",
      "no": "8",
      "type": "벤처투자유형",
      "valid_period": "2026-02-15 ~ 2029-02-14"
    }
  ],
  "company_name": "㈜아리바이오",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 11065499000,
      "cost_of_sales": 4357763000,
      "current_assets": 107457926000,
      "current_liabilities": 9488246000,
      "gross_profit": -551298000,
      "net_income": -32125721000,
      "net_income_bs": -27860401000,
      "non_current_assets": 47469290000,
      "non_current_liabilities": 51149826000,
      "non_operating_expenses": 7830976000,
      "non_operating_income": 1373322000,
      "operating_profit": -25668067000,
      "revenue": 3806465000,
      "sga_expenses": 25116769000,
      "total_assets": 154927216000,
      "total_equity": 94289144000,
      "total_liabilities": 60638073000
    },
    "2023": {
      "capital_stock": 11567285000,
      "cost_of_sales": 6041634000,
      "current_assets": 87292309000,
      "current_liabilities": 11350756000,
      "gross_profit": 9529828000,
      "net_income": -24550023000,
      "net_income_bs": -24550023000,
      "non_current_assets": 59756445000,
      "non_current_liabilities": 60291870000,
      "non_operating_expenses": 18520682000,
      "non_operating_income": 4106450000,
      "operating_profit": -10135791000,
      "revenue": 15571463000,
      "sga_expenses": 19665619000,
      "total_assets": 147048754000,
      "total_equity": 75406129000,
      "total_liabilities": 71642626000
    },
    "2024": {
      "capital_stock": 11994016000,
      "cost_of_sales": 4410872000,
      "current_assets": 86338472000,
      "current_liabilities": 88824457000,
      "gross_profit": 30818100000,
      "net_income": 3867430000,
      "net_income_bs": 3867430000,
      "non_current_assets": 98647329000,
      "non_current_liabilities": 5328427000,
      "non_operating_expenses": 13617895000,
      "non_operating_income": 4172149000,
      "operating_profit": 13313176000,
      "revenue": 35228972000,
      "sga_expenses": 17504924000,
      "total_assets": 184985801000,
      "total_equity": 90832917000,
      "total_liabilities": 94152884000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "920,220,000",
      "changes": "920,220,000",
      "date": "2025-11-18"
    },
    {
      "amount": "16,144,000,000",
      "changes": "16,144,000,000",
      "date": "2022-01-14"
    },
    {
      "amount": "18,394,000,000",
      "changes": "18,394,000,000",
      "date": "2022-01-14"
    },
    {
      "amount": "3,000,004,000",
      "changes": "3,000,004,000",
      "date": "2014-11-14"
    },
    {
      "amount": "399,994,000",
      "changes": "399,994,000",
      "date": "2014-11-14"
    }
  ],
  "main_products": "신약개발, 기능성화장품",
  "phone": "02-2637-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
Employment Insurance2026-02-25
Collected
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected